MedTrace Logo

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

NCT06891040 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2026-04-13

No results posted yet for this study

Summary

A multicenter, randomized, double-blind, vehicle controlled phase II clinical study

Conditions

Interventions

DRUG

VC005 Placebo group

VC005 Placebo group with Local topical application

DRUG

VC005 groups

VC005 group with Local topical application

Sponsors & Collaborators

  • Jiangsu vcare pharmaceutical technology co., LTD

    lead INDUSTRY

Principal Investigators

  • Qian jin Lu · Chinese Academy of Medical Sciences Hospital of Skin Disease

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-28
Primary Completion
2025-10-31
Completion
2025-11-04

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06891040 on ClinicalTrials.gov